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2 
Abstract 23 
Eimeria tenella can cause the disease coccidiosis in chickens. The direct and often 24 
detrimental impact of this parasite on chicken health, welfare and productivity is well 25 
recognised, however less is known about the secondary effects infection may have 26 
on other gut pathogens. Campylobacter jejuni is the leading cause of human 27 
bacterial food-borne disease in many countries and has been demonstrated to exert 28 
negative effects on poultry welfare and production in some broiler lines. Previous 29 
studies have shown that concurrent Eimeria infection can influence colonisation and 30 
replication of bacteria such as Clostridium perfringens and Salmonella Typhimurium. 31 
Through a series of in vivo co-infection experiments, this study evaluated the impact 32 
that E. tenella infection had on C. jejuni colonisation of chickens, including the 33 
influence of variations in parasite dose and sampling time post-bacterial challenge. 34 
Co-infection with E. tenella resulted in a significant increase in C. jejuni colonisation 35 
in the caeca, in a parasite dose dependent manner, but a significant decrease in C. 36 
jejuni in the spleen and liver of chickens. Results were reproducible at three and ten 37 
day’s post-bacterial infection. This work highlights that E. tenella not only has a direct 38 
impact on the health and well-being of chickens but can have secondary effects on 39 
important zoonotic pathogens.    40 
3 
Introduction 41 
Commercial production of chickens has increased dramatically in recent decades 42 
with further expansion predicted (1, 2), increasing their relevance to human food 43 
security and safety. Understanding interactions between infectious agents within the 44 
chicken is important as these can influence animal welfare, commercial success and, 45 
potentially, public health. Interactions within the gut are of particular importance 46 
because the chicken intestinal microbiome influences performance parameters such 47 
as feed conversion ratio and body weight gain (3, 4). Concurrent infections can 48 
influence the colonisation and replication of pathogens in the chicken intestine, a 49 
classic example being enhanced growth of Clostridium perfringens potentiated by 50 
high mucus production induced by co-infecting Eimeria species parasites (5). 51 
Recently, the translocation of Escherichia coli from the gut to internal organs was 52 
shown to be enhanced by co-infection with Campylobacter jejuni (6). Moreover, an 53 
extensive study of commercial broiler flocks showed a strong association between 54 
Campylobacter isolation and rejection of carcasses due to unspecified microbial 55 
infections (7). 56 
Eimeria tenella and C. jejuni are of considerable veterinary and medical significance, 57 
respectively. Eimeria species parasites are ubiquitous under intensive farming 58 
systems (8), have a huge economic impact (9) and can affect colonisation of 59 
pathogenic bacteria such as C. perfringens and Salmonella enterica Typhimurium (5, 60 
10). The use of live Eimeria vaccines in the poultry industry and the development of 61 
Eimeria as a vaccine vector (11, 12) prompted this investigation into the effects that 62 
Eimeria has on other pathogenic agents found in poultry, such as C. jejuni.  63 
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C. jejuni is the leading cause of human bacterial food poisoning in many countries, 64 
with an estimated global burden of 95 million illnesses, 21,000 deaths and 2.1 million 65 
disability-adjusted life years lost in 2010 (13), and can induce severe sequelae 66 
including inflammatory neuropathies such as the Guillain-Barré syndrome (14). 67 
Source attribution studies unequivocally identify chickens as the major reservoir of 68 
this zoonotic infection (15). Campylobacter is environmentally ubiquitous (16) and is 69 
commonly found in and around poultry houses, with horizontal transfer being the 70 
main route of infection for intensively reared broilers (15). The movement of humans 71 
in and out of poultry houses appears to be extremely important in the active carriage 72 
of the bacterium. Studies investigating transmission routes for Campylobacter on 73 
farms have isolated Campylobacter from multiple human sources including hands, 74 
boots and clothes of farm workers, drivers and managers. Molecular analysis found 75 
that in numerous cases these same isolates were subsequently recovered from the 76 
poultry (17). The bacterium is usually undetectable within chicken flocks during the 77 
first few weeks of life and this is thought to be due to the presence of maternal anti-78 
campylobacter IgY antibodies which gradually decrease and disappear after two to 79 
three weeks (18) (19). After this period, once the first bird becomes colonised the 80 
infection spreads quickly throughout the flock via the faecal-oral route (20). C. jejuni 81 
replicates rapidly in the intestinal mucus of chickens and transiently invades 82 
epithelial cells to avoid mucosal clearance (21). Subsequently, C. jejuni can 83 
translocate across the intestinal epithelial barrier and disseminate into deeper 84 
tissues including the liver and spleen, increasing its infectious potential as internally-85 
located bacteria are less likely to be destroyed by cooking than faecal surface 86 
contaminants (22). Increasingly, outbreaks of human campylobacteriosis are linked 87 
to the consumption of undercooked chicken products such as liver paté (23).  88 
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The aim of this study was to investigate the influence of concurrent E. tenella 89 
infection on C. jejuni colonisation in chickens, including investigation of physical and 90 
immunological factors associated with the observed changes. E. tenella causes 91 
haemorrhagic enteritis in the chicken caeca, accompanied by the induction of strong 92 
pro-inflammatory immune responses that includes influx of heterophils, enhanced 93 
mucus production, increased T-cell proliferation and a surge in the expression of a 94 
variety of immune effectors (5, 24-27). We postulated that immune responses and/or 95 
the pathology induced by E. tenella may allow C. jejuni to flourish and breach the 96 
protective gut wall, increasing colonisation and replication within the caeca, liver and 97 
spleen.  98 
 99 
Materials and Methods 100 
Ethics statement 101 
The work described here was conducted in accordance with UK Home Office 102 
regulations under the Animals (Scientific Procedures) Act 1986 (ASPA), with 103 
protocols approved by the Institute for Animal Health and Royal Veterinary College 104 
Animal Welfare and Ethical Review Bodies (AWERB). Study birds were observed 105 
daily for signs of illness and/or welfare impairment and were sacrificed under Home 106 
Office licence by cervical dislocation. 107 
Animals 108 
Light Sussex chickens, purchased from the Institute for Animal Health Poultry 109 
Production Unit (IAH PPU, Compton, UK) were used for all experiments. All chickens 110 
were certified as specific-pathogen free (SPF). Throughout the study all chickens 111 
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had access to food and water ad-libitum and were fed with a standard commercial 112 
poultry grower diet including 20% protein and 55% wheat (LBS-biotech, UK). 113 
Parasites and propagation 114 
The E. tenella Wisconsin (Wis) strain and its derivative, the attenuated WisF96 line 115 
were used throughout these studies (28, 29). The Wis strain is a wild-type (non-116 
attenuated) E. tenella isolate with a standard pre-patent period of ~132 hours. The 117 
WisF96 line has been attenuated by selection for precocious development, resulting 118 
in a single round of schizogony with a reduced pre-patent period of ~96 hours and 119 
much reduced pathology due to the loss of the second generation schizont, which is 120 
responsible for deep tissue damage and haemorrhage (23). Nonetheless, the 121 
WisF96 line retains the ability to induce a fully protective immune response during 122 
natural infection that is comparable to the non-attenuated Wis strain (28). These 123 
parasites are phenotypically stable and were passaged through chickens at the 124 
Institute for Animal Health, and then the Royal Veterinary College through dosing 125 
and recovery as previously described (30), and used in these studies less than one 126 
month after sporulation.  127 
Bacterial propagation 128 
C. jejuni strain 81-176 was used due to its proven ability to efficiently colonise the 129 
chicken gastrointestinal tract (31). Bacteria were routinely cultured in Mueller-Hinton 130 
(MH) broth and on sheep blood agar plates at 37°C for 48 hours in a microaerophilic 131 
atmosphere created using the CampyGen system (all Oxoid, Basingstoke, UK). 132 
Charcoal cefoperazone deoxycholate agar (CCDA, Oxoid) was used to 133 
retrospectively enumerate colony-forming units of C. jejuni administered per animal, 134 
by directly plating 10-fold serial dilutions of the inoculum in phosphate-buffered 135 
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saline (PBS, Oxoid). CCDA was also used to enumerate C. jejuni recovered from 136 
chickens by directly plating 10-fold serial dilutions of homogenates of caecal 137 
contents, liver and spleen (as described below). Plates were incubated at 37°C for 138 
48 hours in a microaerophilic atmosphere, as detailed above. Animals not 139 
challenged using C. jejuni were screened for exposure to Campylobacter by 140 
enrichment of caecal contents using modified Exeter broth as described previously 141 
(31) followed by plating on CCDA plates.  142 
Experimental design 143 
E. tenella/C. jejuni co-infection 144 
Three in vivo trials were undertaken to investigate the influence of the presence and 145 
severity of ongoing E. tenella infection on the outcome of oral C. jejuni challenge.  146 
In trial 1 (pilot study, conducted at the Institute for Animal Health), 24 SPF Light 147 
Sussex chickens were caged in three groups of eight. Chickens in Group 1 received 148 
4,000 sporulated E. tenella Wis (non-attenuated, n) oocysts by oral gavage at 13 149 
days of age (nE+). Chickens in Group 2 received 115,000 sporulated WisF96 150 
(attenuated; a) oocysts by oral gavage at 15 days of age (aE+). Chickens in Group 3 151 
were not infected with E. tenella (E-). Chickens in all three groups received ~108 152 
CFU C. jejuni by oral gavage at 18 days of age (C+). The differential dosing 153 
schedule of nE+/C+ and aE+/C+ was to adjust for the different pre-patent periods of 154 
these parasites, to ensure peak parasitaemia in the caeca at the time of C. jejuni 155 
challenge in both groups. The non-attenuated and attenuated parasite lines were 156 
used to compare the severity of pathology (i.e. presence/absence of the second 157 
generation schizont) and the dose sizes were designed to reduce the confounding 158 
effect of differential parasite replication, although it should be noted that equivalent 159 
8 
oocyst output was not expected (28).  Parasite-associated pathology was only 160 
anticipated for the non-attenuated Wis infected groups. Three days post C. jejuni 161 
challenge (21 days of age) all birds were culled. Post-mortem caecal contents, liver, 162 
and spleen tissue were collected immediately. 163 
Trial 2 followed a similar experimental outline to trial 1 with Groups 1-3 receiving 164 
identical treatment (nE+/C+, aE+/C+, and E-/C+ respectively, undertaken at RVC). In 165 
addition, to directly compare the effect of C. jejuni challenge on parasite replication, 166 
control groups received E. tenella treatment without C. jejuni challenge, using sterile 167 
MH broth in place of C. jejuni (Groups 4-6; E. tenella Wis only: nE+/C-, E. tenella 168 
WisF96 only: aE+/C-, no E. tenella: E-/C-). Groups 1-3 (all C+) comprised ten Light 169 
Sussex chickens per group, while groups 4-6 (all C-) comprised six chickens per 170 
group, reflecting the greater bird to bird variation in C. jejuni enumeration compared 171 
to E. tenella. All birds were caged separately to facilitate collection of individual bird 172 
faeces and enumeration of total daily oocyst output between 18 and 21 days of age 173 
as described previously (32). All birds were culled three days post C. jejuni challenge 174 
(21 days of age) and samples collected as described for trial 1.  175 
Trial 3 was similar to trial 2, except that instead of using the attenuated E. tenella 176 
WisF96 line, a low dose (400 oocysts) of non-attenuated E. tenella Wis was used to 177 
assess the effect of parasite dose/replication, rather than reduced pathogenicity, on 178 
the outcome of C. jejuni infection. In this trial, the culling of birds was delayed to ten 179 
days post C. jejuni challenge to assess if the changes observed in C. jejuni load at 180 
three days (Trials 1 and 2) were stable over a longer period. Additionally, to provide 181 
a semi-quantitative comparison of bacterial load between trials 1, 2 and 3, birds were 182 
swabbed cloacally three days post C. jejuni challenge, as described previously (11). 183 
At 13 days of age, groups 1 and 4 received a high (h) dose of 4,000 sporulated E. 184 
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tenella Wis oocysts (nEh+/C+ and nEh+/C-) whilst groups 2 and 5 received a low (l) 185 
dose of 400 sporulated E. tenella Wis oocysts (nEl+/C+ and nEl+/C-). Chickens in 186 
groups 3 and 6 were not infected with the parasite (E-/C+ and E-/C-).  At 18 days of 187 
age groups 1, 3 and 5 were challenged with ~108 CFU C. jejuni whilst groups 2, 4 188 
and 6 were mock challenged with sterile MH broth. Daily oocyst output was 189 
assessed for each chicken between 18 and 22 days of age. Chickens were culled 190 
ten days post bacterial challenge (28 days of age) and samples collected as 191 
described for trial 1. 192 
Sample collection 193 
Post-mortem, 0.2-1.0 g of caecal contents, liver, and spleen were collected 194 
aseptically from the same ~central part of each tissue/organ into universal tubes and 195 
stored separately on ice prior to homogenisation in all trials. On the day of collection 196 
all samples were weighed and homogenised in an equal volume (w/v) sterile PBS 197 
using a TissueRuptor (Qiagen, Hilden, Germany), followed by serial 10-fold dilutions 198 
in PBS. Additionally, ~3 cm tissue from the mid-point of one caeca, half the spleen, 199 
and ~1 cm3 section of the mid-liver were recovered from chickens in trial 2 and 200 
stored in RNAlater (Sigma) as recommended by the manufacturer for subsequent 201 
RNA extraction and RT-qPCR. 202 
RNA extraction and integrity 203 
Total RNA was extracted from thawed tissue samples after storage at -20°C in 204 
RNAlater using an RNeasy mini kit (Qiagen, Hilden, Germany) according to the 205 
manufacturer’s instructions. The optional DNase digestion step was included to 206 
remove contaminating genomic DNA. RNA concentration was determined using a 207 
Nanodrop ND-2000 spectrophotometer (ThermoScientific, Wilmington, DE, USA) 208 
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and samples were diluted in nuclease free water to produce a final concentration of 209 
40 ng/μL. The quality of a sub-set of samples (~ 5%) was confirmed using an Agilent 210 
RNA 6000 Nano Kit (Agilent Technologies, Waldbronn, Germany) following the 211 
manufacturer’s instructions, confirming RNA Integrity Number results in excess of six 212 
for further analysis. 213 
Real-time quantitative PCR (RT-qPCR) 214 
Superscript II Reverse Transcriptase (RT) (Invitrogen, Carlsbad, USA) was used to 215 
make cDNA using total RNA purified from the samples collected, following the 216 
manufacturer’s instructions. Oligo (dT)12-18 (Invitrogen, Carlsbad, USA) was used 217 
along with the optional RNaseOut (Invitrogen) step. cDNA was used as template in 218 
all RT-PCR reactions. 219 
The oligonucleotide primer sequences used to target cDNA copies of each of the 220 
mRNA transcripts investigated including mucin (MUC) 2, MUC 5ac, MUC 13, IL-1β, 221 
IL-6, IFNγ, IL-2, IL-10, IL-13, inducible nitric-oxide (iNOS), and three reference 222 
transcripts are summarised in Supplementary Table 1. The final reaction volumes for 223 
RT-qPCR consisted of 10 µl SsoFast EvaGreen super mix, containing Sybr Green 224 
dye (Bio-Rad), 70 nM of each primer (Sigma-Aldrich), forward and reverse, and were 225 
made up to 19 µl using RNase and DNase free water (Invitrogen, Paisley, UK). To 226 
one volume of this master-mix 1 µl of cDNA was added. As a negative control, 1 µl of 227 
water was used in place of cDNA. DNA was amplified on a Bio-Rad CFX 2.0 cycler 228 
(Bio-Rad) in triplicate, for every sample, using the following conditions; 1 cycle at 229 
95°C for 60 s followed by 40 cycles of 95 °C for 15 s and the appropriate annealing 230 
temperature (as indicated in Supplementary Table 1) for 30 s. After completion, a 231 
melt curve was generated by running one cycle at 65 °C for 0.05 s and 95 °C for 0.5 232 
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s. Individual transcripts were normalised individually to the three reference genes 233 
and used to calculate a mean figure for each replicate. Briefly, quantification cycle 234 
(Cq) values for each sample were generated using the BioRad CFX 2.0 software and 235 
enabled quantification of cDNA when normalized to the reference genes, 236 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), TATA-binding protein 237 
(TATA-BP), and 28S rRNA.  238 
Statistical analysis 239 
Statistical analyses including calculation of arithmetic means, associated standard 240 
deviation or error of the mean, analysis of variance and associated post-hoc Tukeys 241 
tests were performed using SPSS Statistics v24 (IBM). Bacterial counts were 242 
logarithmically transformed. Differences were considered significant where P < 0.05. 243 
 244 
Results 245 
E. tenella/C. jejuni co-infection 246 
For all three trials, at all sampling sites C. jejuni was not detected above the limit of 247 
detection in any of the unchallenged (C-) birds. 248 
Trial 1 (pilot, Table 1). In the caeca, three days post bacterial challenge, co-infection 249 
with non-attenuated or attenuated E. tenella caused a significant 2.5 or 1 log10 250 
increase in C. jejuni load (P < 0.001 and P < 0.05), respectively, compared to C. 251 
jejuni alone. A significant difference in caecal C. jejuni colonisation was also 252 
detected between the non-attenuated and attenuated parasite groups (P < 0.05). In 253 
the spleen co-infection with either of the E. tenella lines caused a non-significant 1 254 
log10 decrease in C. jejuni load (P > 0.05) compared to C. jejuni alone. Similarly, in 255 
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the liver, co-infection with either parasite line caused a non-significant ~ 1 log10 256 
decrease in C. jejuni load (P > 0.05).  257 
Trial 2. In the caeca, three days post bacterial challenge, co-infection with non-258 
attenuated or attenuated E. tenella caused a significant 2.9 or 1.35 log10 increase in 259 
C. jejuni load, respectively, compared to C. jejuni alone(P < 0.001; Figure 1A). A 260 
significant difference in C. jejuni colonisation was again detected in the caeca 261 
between non-attenuated and attenuated parasite groups (P < 0.001). Here, C. jejuni 262 
load was positively correlated with parasite replication, measured in terms of total 263 
oocyst output (r = 0.893, P < 0.001; Figure 1E). In the liver co-infection with non-264 
attenuated and attenuated E. tenella caused a significant ~ 1 log10 decrease in C. 265 
jejuni (P < 0.05; Figure 1B), although no difference was detected between the 266 
parasite lines (P > 0.05). Similarly, in the spleen co-infection with either E. tenella 267 
line caused a significant 1.8 or 1.1 log10 decrease in C. jejuni, respectively, (P < 0.05; 268 
Figure 1C), with no difference between parasite lines. In both liver and spleen no 269 
association was detected between C. jejuni and the level of faecal oocyst output (P > 270 
0.05; Figures 1F and G). Total oocyst output was higher in chickens infected with 271 
non-attenuated E. tenella compared with the attenuated line (Figure 1D). 272 
Trial 3 (Table 2). Cloacal swabs were collected three days post C. jejuni infection 273 
from all groups. Co-infection initiated with a high non-attenuated E. tenella dose 274 
caused a significant, 1.6 log10 increase in cloacal C. jejuni (P < 0.001), compared to 275 
C. jejuni alone. In the co-infected group with a low parasite dose, no difference in C. 276 
jejuni load was observed (P > 0.05). A significant difference in cloacal C. jejuni load 277 
was noted between the groups co-infected with  high and low parasite doses (P < 278 
0.001). 279 
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In the caeca, ten days post C. jejuni infection, co-infection initiated with a high E. 280 
tenella dose caused a significant 1.5 log10 increase in C. jejuni colonisation 281 
compared to C. jejuni alone (P < 0.01). There was a significant association with 282 
oocyst output (r = 0.682, P = 0.001). Co-infection with the low parasite dose group 283 
did not cause a significant change in C. jejuni colonisation compared to C. jejuni 284 
alone (P < 0.05). Significant variation in the level of C. jejuni colonisation was noted 285 
between the high and low E. tenella groups (P < 0.01). 286 
In the spleen, ten days post C. jejuni infection, no significant difference was detected 287 
in the levels of C. jejuni between in the presence or absence of E. tenella, however a 288 
non-significant (P > 0.05) decreasing trend in C. jejuni colonisation was observed. 289 
No association was detected between C. jejuni in the spleen and the level of faecal 290 
oocyst output (r = -0.44, P > 0.05). 291 
In the liver, ten days post C. jejuni infection, there was a significant decrease in C. 292 
jejuni colonisation in the high dose E. tenella group compared to C. jejuni alone (P < 293 
0.05). No significant changes were observed from the low parasite dose. No 294 
association was detected between C. jejuni in the liver and the level of faecal oocyst 295 
output (r = -0.31, P > 0.05). 296 
Cytokine Response to E. tenella/C. jejuni Challenge 297 
E. tenella infection induces a strong immune response and it was postulated that the 298 
changes in C. jejuni load noted in the co-infection models could be due to an 299 
associated ‘bystander’ immune response. Caecal tissues collected during Trial 2 at 300 
21 days of age were used to investigate the transcription of a variety of cytokines 301 
(i.e. a single time point, equivalent to seven, five and three days after challenge by 302 
Wis, WisF96 and C. jejuni, respectively). The transcriptional fold change of each 303 
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group compared to the uninfected control is summarised in Table 3, along with the 304 
fold change of the co-infected groups, compared to the C. jejuni only group. Infection 305 
with C. jejuni alone significantly increased transcription of IL-1β and iNOS (both P ≤  306 
0.001), as well as IL-13 (P ≤ 0.01). Infection with non-attenuated or attenuated E. 307 
tenella increased caecal transcription of IL-1β, IL-2, IL-6, IL-10, iNOS and IFNγ 308 
significantly when compared to uninfected and C. jejuni only infected groups, 309 
irrespective of C. jejuni co-infection. Transcription of IL-13 was significantly 310 
decreased in all Eimeria infected groups. Accompanying P values indicated in Table 311 
3. 312 
Mucin Gene Transcription in Response to E. tenella/C. jejuni Challenge 313 
Caecal transcription of the mucin genes muc2, muc5ac and muc13 was assessed to 314 
explore the consequences of infection. C. jejuni infection alone resulted in no 315 
difference in muc gene transcription three days post-challenge (Table 3). Infection 316 
with non-attenuated E. tenella resulted in upregulation in muc2, muc5ac and muc13 317 
transcription, most notably muc5ac which was the only muc gene significantly 318 
upregulated during attenuated E. tenella infection. 319 
 320 
Discussion 321 
In vivo trials were carried out to analyse the impact of parasite co-infection on C. 322 
jejuni colonisation of the caeca, spleen and liver of chickens. Local transcription of 323 
selected cytokine and mucin genes was assessed in an effort to explain the 324 
differences detected. It was hypothesised that damage to the caecal epithelial barrier 325 
induced by the haemorrhagic parasite E. tenella and/or the consequential pro-326 
inflammatory immune response would facilitate increased bacterial colonisation in 327 
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the caeca, liver and spleen. Quantification of C. jejuni colonisation at these three 328 
sites revealed significant variation in the presence or absence of concurrent E. 329 
tenella infection, disproving the hypothesis for the liver and spleen. Parasite co-330 
infection was associated with elevated C. jejuni loads within the caecal contents, but 331 
reduced loads in the liver and spleen. Thus, while faecal shedding of C. jejuni was 332 
increased by concomitant E. tenella infection, deep tissue bacterial contamination 333 
was decreased. This is in direct contrast to what has been observed when chickens 334 
are co-infected with Eimeria parasites and either C. perfringens or S. enterica 335 
Typhimurium (5, 10). It has been shown that E. tenella infection can influence the 336 
caecal microflora in a manner that has been reported, by some (33, 34), to 337 
potentially benefit C. jejuni colonisation and demonstrates that E. tenella induced 338 
dysbiosis may increase susceptibility to enteric pathogens such as C. jejuni. Further 339 
analysis of the microbiome of co-infected poultry is needed to investigate this 340 
hypothesis. Increased bacterial load in the gut but not the internal organs due to co-341 
infection with globally enzootic Eimeria parasites (8) is relevant to the food safety risk 342 
posed by C. jejuni. Furthermore, these results are pertinent to the development of 343 
Eimeria as a novel vaccine vector system. This approach aims to utilise transgenic 344 
attenuated strains of the parasite to deliver vaccine antigens to chickens. Live 345 
attenuated vaccines are currently used to vaccinate over one billion birds each year 346 
(11) and results from this study suggest that attenuated strains have the potential to 347 
reduce C. jejuni colonisation in the liver of poultry, which could limit human cases of 348 
campylobacteriosis. Paradoxically, increases in C. jejuni colonisation in the caeca 349 
are of concern, although improvements in abattoir protocols have been associated 350 
with a shift in the importance of surface contamination by faeces to deep tissue 351 
colonisation by C. jejuni, exacerbated by the deliberate undercooking or sautéing of 352 
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chicken liver due to the belief this will enhance the flavour and appearance of the 353 
end product (35). 354 
It is well recognised that individually both E. tenella and C. jejuni generate an 355 
immune response, of varying levels, in chickens following infection (24, 27, 36-38). 356 
The impact of E. tenella co-infection on C. jejuni colonisation and concurrent effect 357 
on cytokine production has not been reported. Previously wild type (non-attenuated) 358 
strains of E. tenella have been shown to induce a significant immune response in 359 
chickens (24, 27), which is far greater than that induced by C. jejuni alone (36, 37). 360 
These findings were replicated in this study, where the transcription of all but one of 361 
the cytokines tested, IL-13, were increased in nE/C- compared to E-/C+ chickens. 362 
Additionally, in this study it is notable that there was a significant increase in the 363 
transcription of the majority of cytokines investigated in aE/C- compared to E-/C+ 364 
chickens, despite considerable attenuation of the WisF96 parasite line. To the best 365 
of our knowledge this is the first report of immune responses associated with in vivo 366 
WisF96 infection. The induction of immune responses in the absence of significant 367 
pathology is relevant to the efficacy of attenuated anticoccidial vaccines. It is 368 
postulated that the reduction in C. jejuni colonisation in the liver and spleen in the co-369 
infection model could be due to an associated, ‘bystander’ immune response 370 
induced by the parasite. E. tenella infection stimulates a strong pro-inflammatory 371 
immune response including significant increases in IFNγ and iNOS (39). iNOS has 372 
also been directly linked to the control of C. jejuni (40). Caecal iNOS transcription 373 
was increased six- or eight-fold during infection with attenuated or non-attenuated E. 374 
tenella. The up-regulation of immune factors linked to control of C. jejuni as a 375 
consequence of an ongoing E. tenella infection may explain, at least in part, the 376 
reduced translocation of C. jejuni to the liver and spleen in co-infected chickens. 377 
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IFNγ levels are balanced by anti-inflammatory cytokines such as IL-10 (41). 378 
Humphrey et al. (2014) reported that regulation of IL-10 is important in controlling 379 
intestinal pathology in C. jejuni infected chickens, where lower levels associated with 380 
prolonged inflammation and diarrhoea (36).In support, Vaezirad et al. (2017) 381 
demonstrated that using glucocorticoids to dampen the immune system of chickens 382 
reduced expression of pro-inflammatory genes and increased the colonisation of C. 383 
jejuni in the caeca as well as translocation to, and colonisation of the liver (42). The 384 
work of Vaezirad et al. (2017) supports the hypothesis that the increase in C. jejuni 385 
caecal colonisation may also be influenced by physical damage. E. tenella infection 386 
causes sloughing of cells which form the epithelial barrier and this damage may 387 
facilitate enhanced C. jejuni colonisation in the caeca, akin to the mechanism utilised 388 
by C. perfringens to invade the gut in the presence of Eimeria (43, 44). 389 
Increased transcription of the majority of cytokines in the caecal tissue in co-infected 390 
birds did not appear to impede C. jejuni colonisation of the caecal contents, although 391 
it is not clear if this was a cause or effect. These results suggest that the 392 
mechanism(s) responsible for the increase in C. jejuni detected within the caecal 393 
lumen is distinct from translocation through the caecal wall and/or deep tissue 394 
colonisation. E. tenella can cause a haemorrhagic form of coccidiosis characterised 395 
by large volumes of blood in the caeca (45). Iron is an essential nutrient for 396 
colonisation of C. jejuni, however bioavailability is limited within many host 397 
environments (46). Bacteria can take up iron via environmental sources, such as 398 
haemin and haemoglobin (47). It is hypothesised that the increased availability of 399 
haemoglobin in the caeca, due to epithelial damage caused by E. tenella, may have 400 
provided C. jejuni with an increased source of iron facilitating enhanced growth and 401 
replication. The apparent pathology-dependent effect between non-attenuated and 402 
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attenuated parasite infections supports such a hypothesis, and it is noted that the 403 
attenuated line was expected to induce little or no haemorrhage. Attenuated E. 404 
tenella are less pathogenic than the non-attenuated parasite (48) and cause less 405 
damage to the intestinal epithelium, but still induce an equivalent immune response 406 
(49). The subsequent comparison of high and low non-attenuated parasite doses 407 
confirmed a dose-effect of Eimeria on C. jejuni colonisation within the caecal 408 
contents, but not the liver or spleen, supporting the association between pathological 409 
severity in the former but not the latter. While the parasite crowding effect is 410 
expected to have reduced the scale of difference between the high and low doses by 411 
the time of oocyst excretion (50), it is clear that pathology (lesion score) does 412 
associate with dose level (51). Variation in unidentified immune factors may 413 
contribute to this effect and could influence the increased caecal C. jejuni load in 414 
chickens co-infected with the attenuated parasite, where caecal pathology would 415 
have been minimal. 416 
Trials one and two explored the impact of an ongoing infection with non-attenuated 417 
or attenuated E. tenella on C. jejuni colonisation of chickens’ three-days after 418 
bacterial challenge. The healthy chicken caeca empties several times per day, 419 
suggesting that the figures recorded represent true bacterial colonisation (52). 420 
However, to confirm the association the study was repeated using a later sampling 421 
point, revealing similar results at ten compared to three days post bacterial 422 
challenge. Once C. jejuni contaminated food or faecal material is ingested by the 423 
chicken transit time through the upper gastrointestinal tract is ~2.5 hours (53). Work 424 
by Shaughnessy et al. (2009), using a similar inoculating dose to those used in this 425 
study, showed high levels of persistent caecal colonisation at 6, 20 and 48 hours 426 
post C. jejuni infection, indicating rapid colonisation of the bacteria in the caeca (38). 427 
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Meade et al. (2009) showed that the liver and spleen of the majority of birds were 428 
colonised by C. jejuni 48 hours post infection (54). These studies support analysis of 429 
C. jejuni colonisation in the E. tenella co-infection model three days post bacterial 430 
infection, confirmed at ten days post infection. Practically, these results are also 431 
relevant to the field situation where anticoccidial drugs are commonly withdrawn from 432 
broiler diets three to five days prior to slaughter, indicating a risk of a parasite and 433 
associated C. jejuni surge at the time of transportation and carcass processing. 434 
In addition to haemorrhage, several Eimeria species have been associated with 435 
enteric mucogenesis in chickens (5). C. jejuni has been shown to replicate rapidly in 436 
intestinal mucus from chickens (21), suggesting that a mucogenic response may 437 
encourage Campylobacter proliferation within the mucus layer. Bacterial proteins 438 
required for motility and colonisation, including flagellin A and Campylobacter 439 
invasion antigens, are known to be secreted in the presence of chicken mucus (55, 440 
56). Chicken mucus has also been shown to enhance C. jejuni motility and 441 
expression of the flagellar protein FlgR (57), to protect C. jejuni from some short and 442 
medium-chain fatty acids (58) (59), and the viscous environment might aid binding 443 
and invasion of mammalian cells (60). However, enteric mucus from chickens has 444 
also been reported to attenuate C. jejuni 81-176 invasion of both avian and human 445 
epithelial cells (61), possibly contributing to reduced translocation away from the 446 
caeca. Mucins are a major component of mucus and in this study the transcription of 447 
muc2, muc5ac (both secreted, mucus forming mucins (62)) and muc13 (a 448 
transmembrane mucin) increased in the presence of non-attenuated E. tenella. 449 
Transcription of muc5ac was also increased during attenuated E. tenella infection. It 450 
was therefore postulated that intestinal mucus could play a key role in the enteric 451 
colonisation of C. jejuni in chickens and the interaction with E. tenella. A pilot study 452 
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investigating the impact of the mucus-thinning dietary supplement N-acetylcysteine 453 
(NAC, Sigma-Aldrich) (63, 64) was carried out during an in vivo co-infection trial to 454 
test this theory (summarised in Supplemental materials, Methods and 455 
Supplementary Table 2). It was hypothesised that inclusion of a mucus-thinning 456 
agent in the feed of chickens would balance E. tenella induced mucus secretion, 457 
directly reducing nutrient availability in the caecal lumen and indirectly C. jejuni 458 
replication and colonisation. Further, depleting the secreted mucus layer might be 459 
expected to facilitate increased translocation to extra-intestinal sites such as the liver 460 
and spleen. In mucin 2 deficient mice presenting with a diminished intestinal barrier, 461 
infection and mortality caused by S. enterica serovar Typhimurium was increased 462 
(65). Here, using periodic acid Schiff (PAS) staining it was not possible to detect any 463 
consistent variation in the thickness or consistency of the intestinal mucus layer with 464 
NAC supplementation. As a consequence no direct functional conclusions can be 465 
drawn. However, NAC supplementation did abrogate the E. tenella-associated 466 
increase in caecal C. jejuni load, with a further non-significant reduction in treated 467 
compared to untreated single C. jejuni infected chickens. These results support the 468 
view that chicken mucus may aid C. jejuni colonisation and/or replication, possibly 469 
via the provision of nutrients required for sustained growth (66), but further work will 470 
be required for confirmation. NAC supplementation is also likely to have exerted 471 
other profound effects on the broader enteric microbiome, the influence of which is 472 
not currently known. Interestingly, the significant decreases detected in C. jejuni 473 
colonisation of the liver and spleen in the co-infection model were maintained in the 474 
presence of NAC, suggesting either a limited role for mucus in this aspect of the 475 
parasite-bacterial interaction or inefficacy of the NAC protocol.  476 
 477 
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Conclusion 478 
The current study has demonstrated that E. tenella co-infection exerts a significant 479 
impact on colonisation of C. jejuni in Light Sussex chickens, while upregulating 480 
several relevant immune factors. Co-infection caused a significant increase in C. 481 
jejuni colonisation in the caecal contents, in a parasite pathology and dose 482 
dependent manner, but a decrease in the liver and spleen. Results were 483 
reproducible on days three and ten post-bacterial challenge, highlighting the stability 484 
of the effect. Investigation into the levels of mucin transcription suggested that the 485 
presence of a depleted intestinal mucosal barrier may contribute. Similar co-infection 486 
studies with broiler chickens raised under intensive conditions are required to assess 487 
if these results are reproducible in a commercial setting. Building on these studies, 488 
the influence of eimerian infection on C. jejuni colonisation of poultry may impact 489 
both the use of live anticoccidial vaccines and the development of Eimeria as a novel 490 
vaccine vector. 491 
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Figure legends 692 
Figure 1. (A-C) C. jejuni load in single or co-infected Light Sussex chickens (Trial 2). 693 
Circle = count per bird (log10). X = average count per treatment group (log10). (A) 694 
Caecal contents. (B) Liver. (C) Spleen. (D) Total log10 E. tenella oocyst output per 695 
bird (circle) and average per group (X). (E-G) Relationship between C. jejuni load 696 
and E. tenella oocyst output. Solid markers = non-attenuated E. tenella, hollow 697 
markers = attenuated E. tenella. (E) Caecal contents. (F) Liver. (G) Spleen. (Key) 698 
Group identifiers and experimental schedule. nE = non-attenuated E. tenella 699 
Wisconsin, aE = attenuated E. tenella WisF96, C = C. jejuni 81-176. + = 700 
administered. - = not administered, mock control. LD = limit of detection. Groups with 701 
different superscript letters within plot indicate significant statistical differences. 702 
  703 
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Table 1.  Campylobacter jejuni and Eimeria tenella dose regimes and viable counts from single and co-infection of chickens in Trial 706 
1.  707 
Group1 E. tenella strain  
(dose; age at dosing)  
C. jejuni 
Log10 CFU 
(d18) 
Log10 CFU/g Day 21 (three days post C. 
jejuni) Average ± SD 
 
Caeca Liver Spleen 
nE+/C+ Wis (4,000; d13) 8.17 9.13 ± 0.19a 2.03 ± 1.22a 1.67 ± 1.51a 
aE+/C+ WisF96 (115,000; d15) 8.17  7.55 ± 0.62b  2.03 ± 1.23a  1.35 ± 1.20a 
E-/C+ None 8.17  6.61 ± 1.77c  2.91 ± 1.53a 2.70 ± 1.71a  
nE = non-attenuated E. tenella Wis, aE = attenuated E. tenella WisF96, C = C. jejuni, + = administered, - = not administered. 1= 8 708 
birds/group. Averages that were significantly different within each column are identified by a different superscript letter (p < 0.05). 709 
 710 
  711 
29 
Table 2.  Campylobacter jejuni and Eimeria tenella dose regimes and viable counts from single and co-infection of chickens in Trial 712 
3.  713 
Group1 E. tenella strain 
(dose; age at 
dosing)  
C. jejuni 
Log10 CFU 
(d18) 
Log10 output 
oocysts per 
bird 
Log10 CFU/g (Average ± SD) 
 
Day 212 Day 283 
 
Cloacal swab Caeca Liver Spleen 
nEh+/C+ Wis (4000; d13) 8.27  7.28 ± 0.06a 9.16 ± 0.51a 8.47 ± 0.51a  1.99 ± 0.19a 2.42 ± 0.50a 
nEl+/C+ Wis (400; d13) 8.27  6.75 ± 0.09b 7.64 ± 0.49b 7.05 ± 0.93b  2.72 ± 0.26ab 2.60 ± 0.47a 
E-/C+ None 8.27  nd 7.56 ± 0.54b 6.97 ± 1.03b 3.06 ± 0.32b 3.27 ± 0.82a 
nEh+/C- Wis (4000; d13) Mock  7.28 ± 0.04a nd nd nd nd 
nEl+/C- Wis (400; d13) Mock  6.73 ± 0.07b nd nd nd nd 
E-/C- None Mock  nd nd nd nd nd 
nE = non-attenuated E. tenella Wis, C = C. jejuni, h = high dose, l = low dose, + = administered, - = not administered, nd = none 714 
detected. 1= 8 birds/group. 2Sampled three days post-C. jejuni inoculation. 3Sampled ten days post-C. jejuni inoculation. Averages 715 
that were significantly different within each column are identified by a different superscript letter (p < 0.05). Mock = no bacterial 716 
control. 717 
 718 
 719 
 720 
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Table 3. Transcriptional fold change of cytokines and mucins in caecal tissue collected during Trial 2. 721 
 Fold change (±SEM) versus uninfected Fold change (±SEM) versus C. 
jejuni only infected group 
Target Gene nE+/C+ aE+/C+ E-/C+ nE+/C- aE+/C- nE+/C+ aE+/C+ 
IL-1β 11.88*** ±0.55 11.33**±0.71 8.4***±0.40 10.6***±0.62 11.1*** ±0.97 1.42***±0.06 1.35**±0.08 
IL-2  11.87***±0.88 10.37***±1.01 3.07 ns±0.17 10.03***±0.73 7.97***±0.79 3.87***±0.29 3.38***±0.33 
IL-6 18.86***±1.36 20.24***±1.15 3.83ns±0.20 18.12***±1.66 14.37***±1.27 4.92***±0.35 5.28***±0.30 
IL-10 9.89***±0.78 9.06***±0.61 2.09 ns±0.15 8.18***±1.13 8.97***±0.91 4.74***±0.37 4.34***±0.29 
IL-13 -20***±0.003 -16.67***±0.004 1.34 **±0.09 -25***±0.004 -16.67***±0.006 -27.03***±0.003 -21.01***±0.003 
iNOS 8.72***±0.43 6.33***±0.31 4.56***±0.26 8.73***±0.60 5.94***±0.32 1.91***±0.09 1.39**±0.06 
IFNγ 34.60***±1.84 29.96***±1.42 5.02ns±0.18 35.37***±1.54 32.84***±1.16 6.89***±0.37 5.96***±0.28 
MUC2 1.41***±0.06 1.19ns±0.05 1.00ns±0.04 1.41**±0.06 1.16ns±0.04 1.41***±0.06 1.19ns±0.06 
MUC5ac 3.27***±0.23 2.75***±0.15 1.22ns±0.10 3.16***±0.19 2.69***±0.15 2.68***±0.18 2.25***±0.12 
MUC13 1.83***±0.11 1.33ns±0.09 1.20ns±0.08 1.82***±0.06 1.34ns±0.07 1.53***±0.10 1.11ns±0.08 
nE = non-attenuated E. tenella Wis, aE = attenuated E. tenella WisF96, C = C. jejuni, + = administered, - = not administered. Fold change data that were 722 
significantly different are identified by asterisks (ns = not significant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). Samples were collected 3 days post C. jejuni challenge. 723 
